54 related articles for article (PubMed ID: 2856888)
1. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.
Maton PN; O'Dorisio TM; Howe BA; McArthur KE; Howard JM; Cherner JA; Malarkey TB; Collen MJ; Gardner JD; Jensen RT
N Engl J Med; 1985 Jan; 312(1):17-21. PubMed ID: 2856888
[No Abstract] [Full Text] [Related]
2. Pancreatic cholera: beneficial effects of treatment with streptozotocin.
Kahn CR; Levy AG; Gardner JD; Miller JV; Gorden P; Schein PS
N Engl J Med; 1975 May; 292(18):941-5. PubMed ID: 163965
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Sensitivity to Radiotherapy in Endometrial Cancer.
Sorolla MA; Parisi E; Sorolla A
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679719
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.
Cidon EU
World J Gastrointest Oncol; 2017 Jan; 9(1):4-20. PubMed ID: 28144395
[TBL] [Abstract][Full Text] [Related]
5. A new era for the systemic therapy of neuroendocrine tumors.
Eads JR; Meropol NJ
Oncologist; 2012; 17(3):326-38. PubMed ID: 22357730
[TBL] [Abstract][Full Text] [Related]
6. VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide.
Elshafie O; Grant C; Al-Hamdani A; Jain R; Woodhouse N
Sultan Qaboos Univ Med J; 2011 Feb; 11(1):104-7. PubMed ID: 21509215
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.
de Herder WW; Lamberts SW
Endocrine; 2003 Apr; 20(3):285-90. PubMed ID: 12721509
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
Arnold R; Trautmann ME; Creutzfeldt W; Benning R; Benning M; Neuhaus C; Jürgensen R; Stein K; Schäfer H; Bruns C; Dennler HJ
Gut; 1996 Mar; 38(3):430-8. PubMed ID: 8675099
[TBL] [Abstract][Full Text] [Related]
9. 111In-octreotide scintigraphy: a tool to select patients with endocrine pancreatic tumors for octreotide treatment?
Keymeulen B; Bossuyt A; Peeters TL; Somers G
Ann Nucl Med; 1995 Aug; 9(3):149-52. PubMed ID: 8534589
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
Krenning EP; Kwekkeboom DJ; Bakker WH; Breeman WA; Kooij PP; Oei HY; van Hagen M; Postema PT; de Jong M; Reubi JC
Eur J Nucl Med; 1993 Aug; 20(8):716-31. PubMed ID: 8404961
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors.
Arnold R; Neuhaus C; Benning R; Schwerk WB; Trautmann ME; Joseph K; Bruns C
World J Surg; 1993; 17(4):511-9. PubMed ID: 8395752
[TBL] [Abstract][Full Text] [Related]
12. Octreotide effectively decreases mucosal damage in experimental colitis.
Eliakim R; Karmeli F; Okon E; Rachmilewitz D
Gut; 1993 Feb; 34(2):264-9. PubMed ID: 8381760
[TBL] [Abstract][Full Text] [Related]
13. Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.
Farthing MJ
Gut; 1994; 35(3 Suppl):S5-10. PubMed ID: 8206397
[TBL] [Abstract][Full Text] [Related]
14. Antidiarrheal therapy. Prospects for new agents.
Fedorak RN; Field M
Dig Dis Sci; 1987 Feb; 32(2):195-205. PubMed ID: 3542447
[TBL] [Abstract][Full Text] [Related]
15. Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal profiles in insulin-treated type II diabetic patients.
Candrina R; Giustina G
J Endocrinol Invest; 1988; 11(7):501-7. PubMed ID: 3049768
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.
Wiedenmann B; Räth U; Rädsch R; Becker F; Kommerell B
Klin Wochenschr; 1988 Jan; 66(2):75-7. PubMed ID: 2894481
[TBL] [Abstract][Full Text] [Related]
17. The effect of somatostatin on experimental intestinal obstruction.
Mulvihill SJ; Pappas TN; Fonkalsrud EW; Debas HT
Ann Surg; 1988 Feb; 207(2):169-73. PubMed ID: 2893593
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel.
Dueno MI; Bai JC; Santangelo WC; Krejs GJ
Dig Dis Sci; 1987 Oct; 32(10):1092-6. PubMed ID: 2888608
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.
Plewe G; Schrezenmeir J; Nölken G; Krause U; Beyer J; Kasper H; del Pozo E
Klin Wochenschr; 1986 Apr; 64(8):389-92. PubMed ID: 2871221
[TBL] [Abstract][Full Text] [Related]
20. Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea.
Edwards C; Cann PA; Read NW; Holdsworth CD
Gut; 1986 May; 27(5):581-6. PubMed ID: 2870957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
